Bruderman Asset Management’s Gilead Sciences GILD Stock Holding History

Bruderman Asset Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$579K	Sell	9,366 -721	-7%	-$44.6K	1.04%	37
2022 Q1	$603K	Sell	10,087 -10,816	-52%	-$691K	0.91%	43
2021 Q4	$1.52M	Sell	20,903 -58,200	-74%	-$4.01M	1.16%	28
2021 Q3	$5.53M	Buy	79,103 +1,167	+1%	+$82K	1.39%	24
2021 Q2	$5.37M	Buy	77,936 +879	+1%	+$58.7K	1.66%	24
2021 Q1	$4.98M	Buy	77,057 +1,367	+2%	+$88.1K	1.38%	25
2020 Q4	$4.41M	Buy	75,690 +3,452	+5%	+$208K	1.28%	30
2020 Q3	$4.57M	Sell	72,238 -4,329	-6%	-$300K	1.5%	24
2020 Q2	$5.82M	Buy	76,567 +1,245	+2%	+$95.4K	1.93%	14
2020 Q1	$5.46M	Buy	75,322 +1,164	+2%	+$80.4K	2.16%	12
2019 Q4	$4.84M	Sell	74,158 -3,112	-4%	-$203K	1.51%	25
2019 Q3	$5.05M	Buy	+77,270	New	+$5.05M	1.28%	27
2019 Q2	–	Sell	-785	Closed	-$51K	–	276
2019 Q1	$51K	Sell	785 -350	-31%	-$23.3K	0.01%	265
2018 Q4	$71K	Buy	1,135 +581	+105%	+$40.6K	0.02%	213
2018 Q3	$43K	Hold	554	–	–	0.01%	204
2018 Q2	$39K	Hold	554	–	–	0.01%	224
2018 Q1	$42K	Buy	+554	New	+$44K	0.01%	219
2017 Q3	–	Sell	-554	Closed	-$39K	–	204
2017 Q2	$39K	Buy	+554	New	+$36.9K	0.01%	234
2017 Q1	–	Sell	-554	Closed	-$40K	–	200
2016 Q4	$40K	Hold	554	–	–	0.01%	221
2016 Q3	$44K	Hold	554	–	–	0.01%	212
2016 Q2	$46K	Hold	554	–	–	0.01%	207
2016 Q1	$51K	Sell	554 -47	-8%	-$4.24K	0.02%	192
2015 Q4	$61K	Hold	601	–	–	0.02%	192
2015 Q3	$59K	Buy	601 +32	+6%	+$3.55K	0.02%	195
2015 Q2	$67K	Buy	569 +15	+3%	+$1.64K	0.03%	193
2015 Q1	$54K	Buy	+554	New	+$56.3K	0.02%	203

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bruderman Asset Management's GILD Position: Q2 2022 in Review

Bruderman Asset Management reduced its Gilead Sciences (GILD) stake by 7.1% in Q2 2022, selling an estimated $44.6K and leaving 9,366 shares worth $579K. The position accounts for 1.04% of the portfolio, ranked #37.

Bruderman Asset Management first reported a position in GILD in Q1 2015 and has held it in 26 quarters since. The position peaked at $5.82M in Q2 2020. 1,603 funds tracked by Wall St. Rank hold GILD as of Q2 2022.

Bruderman Asset Management held 9,366 shares of Gilead Sciences worth $579K as of Q2 2022.
Bruderman Asset Management sold 721 Gilead Sciences shares in Q2 2022, an estimated $44.6K.
Gilead Sciences made up 1.04% of Bruderman Asset Management's portfolio in Q2 2022, its #37 holding.
Bruderman Asset Management first reported a position in Gilead Sciences in Q1 2015 and has held it in 26 quarters since.
Bruderman Asset Management's Gilead Sciences position peaked at $5.82M in Q2 2020.
1,603 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2022.

Based on Bruderman Asset Management's 13F filing for Q2 2022, filed 15 Aug 2022.